Privacy Policy
Effective Date: April 27, 2026
Last Updated: April 27, 2026
bioAffinity Technologies, Inc. (“bioAffinity,” “we,” “our,” or “us”) is committed to protecting the privacy and security of visitors to our website, including our Investor Relations section. This Privacy Policy describes how we collect, use, disclose, and safeguard information obtained through our website.
1. Scope of This Policy
This Privacy Policy applies to information collected through:
- Our corporate website
- Our Investor Relations (“IR”) pages
- Investor email alert signups and inquiry forms
This policy does not apply to information collected through clinical services, laboratory testing, or other healthcare operations.
2. Information We Collect
Information You Provide Voluntarily
We may collect personal information that you provide directly, including:
- Name
- Email address
- Telephone number
- Mailing address
- Company or affiliation (if provided)
- Any information submitted through contact forms or investor inquiries
Investor Communications Data
If you subscribe to investor alerts, we collect your contact details and communication preferences to deliver:
- Press releases
- SEC filings
- Financial results
- Corporate updates
Automatically Collected Information
We may automatically collect certain information when you visit our website, including:
- IP address
- Browser type and device information
- Pages visited and time spent on the site
- Referring URLs
This information is collected using cookies and similar technologies.
3. How We Use Information
We use the information we collect to:
- Provide investor communications and updates
- Respond to inquiries from investors, analysts, and stakeholders
- Operate, maintain, and improve our website and IR platform
- Monitor usage trends and website performance
- Comply with legal and regulatory obligations
4. Sharing of Information
bioAffinity does not sell personal information.
We may share information with:
- Service providers that support website hosting, analytics, and investor communications
- Investor Relations platform providers that manage email alerts and IR website functionality
- Our affiliates and subsidiaries, for purposes consistent with this Privacy Policy
- Regulatory authorities, courts, or other governmental bodies when required to comply with applicable laws, regulations, or legal processes, including securities regulations
All third-party providers are expected to handle information in a secure and confidential manner and to use it only for the purposes for which it was disclosed.
5. Cookies and Tracking Technologies
We use cookies and similar technologies to:
- Enhance user experience
- Understand how visitors interact with our website
- Support analytics and performance measurement
You can control or disable cookies through your browser settings.
6. Third-Party Links
Our website, including the Investor Relations section, may contain links to third-party websites such as:
- SEC filings hosted on the EDGAR database
- Stock quote and financial data providers
bioAffinity is not responsible for the privacy practices or content of these external websites.
7. Healthcare Information Disclaimer
bioAffinity operates in the healthcare and diagnostic space, including development of technologies such as CyPath® Lung. However, the Investor Relations section of this website does not collect, store, or process Protected Health Information (PHI) and is not subject to the Health Insurance Portability and Accountability Act (HIPAA).
8. Data Security
We implement reasonable administrative, technical, and physical safeguards designed to protect personal information from unauthorized access, disclosure, or misuse. However, no internet-based system can be guaranteed to be completely secure.
9. Data Retention
We retain personal information only for as long as necessary to fulfill the purposes described in this Privacy Policy, unless a longer retention period is required or permitted by law. In general:
- Investor contact information and communication records are retained for as long as you remain subscribed to investor communications and for a reasonable period thereafter to comply with recordkeeping obligations
- Website usage data (such as analytics data) is typically retained for up to 12–26 months
- Information maintained to comply with legal, regulatory, or reporting obligations may be retained for longer periods as required under applicable law or corporate record retention policies
We may also retain information as necessary to resolve disputes, enforce our agreements, and comply with legal obligations.
10. Your Rights and Choices
You may:
- Unsubscribe from investor communications at any time using the link provided in emails
- Request access, correction, or deletion of your personal information, subject to applicable legal requirements
To make a request, please contact us using the information below.
11. Children’s Privacy
Our website and Investor Relations pages are not directed to individuals under the age of 13. We do not knowingly collect personal information from children.
12. Changes to This Policy
We may update this Privacy Policy from time to time. The date the privacy policy was last updated is identified at the top of the page. Updates will be posted on this page with a revised “Last Updated” date. We may email or otherwise communicate reminders about this policy, but you should check our page periodically to see the current policy and any changes we have made to it.
13. Contact Information
If you have questions about this Privacy Policy or our data practices, please contact:
bioAffinity Technologies, Inc.
info@bioaffinitytech.com
210.698.5334
3300 Nacogdoches Road Suite 216
San Antonio, TX 78217
14. Forward-Looking Statements
The Investor Relations section of this website may contain forward-looking statements subject to risks and uncertainties. Please refer to our filings with the U.S. Securities and Exchange Commission for additional information.